EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The TRUST trial in ovarian cancer: a missed opportunity or a turning point? The position of the Italian MITO group

Martina Arcieri, Sandro Pignata, Domenica Lorusso, Anna Fagotti, Vito Chiantera, Antonino Ditto, Giorgio Valabrega, Claudia Marchetti, Claudio Zamagni, Valentina Tuninetti, Alberto Farolfi, Stefano Restaino und 1 weitere

Frontiers in Oncology · 28.05.2026 · 16

DOI: 10.3389/fonc.2026.1853078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 28.05.2026. Verfasst von Martina Arcieri und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Azienda Sanitaria Universitaria Friuli Centrale, Ospedale Santa Maria della Misericordia, Udine, Italy. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Cytoreductionneoadjuvant chemotherapyovarian cancerrandomized clinical trialsurgery

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, Azienda Sanitaria Universitaria Friuli Centrale, Ospedale Santa Maria della Misericordia, Udine, Italy.
  • Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy.
  • Department of Biomedical Sciences, Humanitas University, Milan, Italy.
  • Department of Gynecologic Oncology, Humanitas San Pio X, Milan, Italy.
  • Gynecologic Oncology Unit, Department of Women, Children and Public Health Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Catholic University of the Sacred Heart, Rome, Italy.

Zitieren

APA

Arcieri, M., Pignata, S., Lorusso, D., Fagotti, A., Chiantera, V., Ditto, A., Valabrega, G., Marchetti, C., Zamagni, C., Tuninetti, V., Farolfi, A., Restaino, S., & Vizzielli, G. (2026). The TRUST trial in ovarian cancer: a missed opportunity or a turning point? The position of the Italian MITO group. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1853078

Vancouver

Arcieri M, Pignata S, Lorusso D, Fagotti A, Chiantera V, Ditto A, et al. The TRUST trial in ovarian cancer: a missed opportunity or a turning point? The position of the Italian MITO group. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1853078

BibTeX
@article{Arcieri2026,
  author = {Arcieri, Martina and Pignata, Sandro and Lorusso, Domenica and Fagotti, Anna and Chiantera, Vito and Ditto, Antonino and Valabrega, Giorgio and Marchetti, Claudia and Zamagni, Claudio and Tuninetti, Valentina and Farolfi, Alberto and Restaino, Stefano and Vizzielli, Giuseppe},
  title = {The TRUST trial in ovarian cancer: a missed opportunity or a turning point? The position of the Italian MITO group},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1853078}
}
Kostenlos starten →